Invuity Inc. 01.10.17
Invuity Inc., a surgical photonics company, has appointed Andy Sale as senior vice president of global sales. Sale brings to the position more than 17 years of experience in the medical device industry.
“Our organization will be strengthened by the addition of Andy Sale. Andy is a proven sales leader with deep experience in building high-performance sales teams and driving significant revenue growth,” said president and CEO Philip Sawyer. “Andy’s experience will be particularly impactful as we continue to scale our business across multiple product lines.”
Sale has more than 17 years of medical device sales experience including 11 years at Intuitive Surgical, where he served in a variety of roles including sales manager, sales director, area vice president, regional vice president and in his last role was responsible for all the U.S. capital business. Prior to Intuitive Surgical, Sale spent six years at Johnson & Johnson, where he provided sales and sales leadership in key specialty companies inside of Ethicon to drive the growth of emerging products.
Preliminary 2016 Revenue
The company announced that based on preliminary unaudited financial results, it expects total revenue for the fourth quarter ended Dec. 31, 2016, to range between $9.1 million and $9.3 million. Full-year 2016 revenue is expected to fall between $32.2 million and $32.4 million.
The company also reiterated revenue guidance for 2017 in the range of $42 million to $44 million.
Invuity develops and markets advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during open minimally invasive and minimal access surgery. The company's patented Intelligent Photonics technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include breast and thyroid oncology, plastic reconstructive, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, Calif.
“Our organization will be strengthened by the addition of Andy Sale. Andy is a proven sales leader with deep experience in building high-performance sales teams and driving significant revenue growth,” said president and CEO Philip Sawyer. “Andy’s experience will be particularly impactful as we continue to scale our business across multiple product lines.”
Sale has more than 17 years of medical device sales experience including 11 years at Intuitive Surgical, where he served in a variety of roles including sales manager, sales director, area vice president, regional vice president and in his last role was responsible for all the U.S. capital business. Prior to Intuitive Surgical, Sale spent six years at Johnson & Johnson, where he provided sales and sales leadership in key specialty companies inside of Ethicon to drive the growth of emerging products.
Preliminary 2016 Revenue
The company announced that based on preliminary unaudited financial results, it expects total revenue for the fourth quarter ended Dec. 31, 2016, to range between $9.1 million and $9.3 million. Full-year 2016 revenue is expected to fall between $32.2 million and $32.4 million.
The company also reiterated revenue guidance for 2017 in the range of $42 million to $44 million.
Invuity develops and markets advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during open minimally invasive and minimal access surgery. The company's patented Intelligent Photonics technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include breast and thyroid oncology, plastic reconstructive, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, Calif.
